Literature DB >> 11796143

Cellular mechanisms of nicotine addiction.

J A Dani1, M De Biasi.   

Abstract

In developed countries, tobacco use is estimated to be the largest single cause of premature death [Lancet 339 (1992) 1268]. Nicotine is the main addictive component of tobacco that motivates continued use despite the harmful effects. Nicotinic acetylcholine receptors (nAChRs) are widely distributed throughout the mammalian central nervous system (CNS), where they normally respond to acetylcholine (ACh) and modulate neuronal excitability and synaptic communication. Nicotinic receptors are structurally diverse and have varied roles. Presynaptic and preterminal nAChRs enhance neurotransmitter release. Postsynaptic and somal nAChRs mediate a small proportion of fast excitatory transmission and modulate cytoplasmic second messenger systems. Although the impact of nicotine obtained from tobacco is not completely understood, a portion of nicotine's addictive power is attributable to actions upon the dopaminergic systems, which normally help to reinforce rewarding behaviors. As obtained from tobacco, nicotine activates and desensitizes nAChRs, and both processes contribute to the cellular events that underlie nicotine addiction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11796143     DOI: 10.1016/s0091-3057(01)00652-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  122 in total

Review 1.  Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence.

Authors:  Kelly P Cosgrove; Irina Esterlis; Graeme F Mason; Frederic Bois; Stephanie S O'Malley; John H Krystal
Journal:  Neuropharmacology       Date:  2011-01-27       Impact factor: 5.250

2.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

Review 3.  From smoking to lung cancer: the CHRNA5/A3/B4 connection.

Authors:  M R D Improgo; M D Scofield; A R Tapper; P D Gardner
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

4.  Effect of Abstinence on Audio-Visual Reaction Time in Chronic Smokers Pursuing a Professional Course.

Authors:  Aditya Lal Vallath; Anuradha Rajiv Joshi; Savita Madhukar Vaidya
Journal:  J Clin Diagn Res       Date:  2015-12-01

Review 5.  Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement.

Authors:  Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Matthew I Palmatier; Xiu Liu; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2005-10-21       Impact factor: 4.530

6.  Functional polymorphisms in the human beta4 subunit of nicotinic acetylcholine receptors.

Authors:  Yong Liang; Ramiro Salas; Lisa Marubio; Dani Bercovich; Mariella De Biasi; Arthur L Beaudet; John A Dani
Journal:  Neurogenetics       Date:  2004-11-25       Impact factor: 2.660

Review 7.  Smoking cessation: significance and implications for children.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

8.  Early postnatal parathion exposure in rats causes sex-selective cognitive impairment and neurotransmitter defects which emerge in aging.

Authors:  Edward D Levin; Olga A Timofeeva; Liwei Yang; Ann Petro; Ian T Ryde; Nicola Wrench; Frederic J Seidler; Theodore A Slotkin
Journal:  Behav Brain Res       Date:  2009-12-17       Impact factor: 3.332

9.  The influence of chronic cigarette smoking on neurocognitive recovery after mild traumatic brain injury.

Authors:  Timothy C Durazzo; Linda Abadjian; Adam Kincaid; Tobias Bilovsky-Muniz; Lauren Boreta; Grant E Gauger
Journal:  J Neurotrauma       Date:  2013-06-06       Impact factor: 5.269

10.  Effects of COMT genotype on sensory gating and its modulation by nicotine: Differences in low and high P50 suppressors.

Authors:  S de la Salle; D Smith; J Choueiry; D Impey; T Philippe; H Dort; A Millar; P Albert; V Knott
Journal:  Neuroscience       Date:  2013-03-25       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.